These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 9493123

  • 1. Candesartan cilexetil reduces chronic renal allograft injury in Fisher-->Lewis rats.
    Mackenzie HS, Ziai F, Nagano H, Azuma H, Troy JL, Rennke HG, Tilney NL, Brenner BM.
    J Hypertens Suppl; 1997 Dec; 15(6):S21-5. PubMed ID: 9493123
    [Abstract] [Full Text] [Related]

  • 2. Effects of candesartan cilexetil (TCV-116) and enalapril in 5/6 nephrectomized rats.
    Noda M, Fukuda R, Matsuo T, Ohta M, Nagano H, Imura Y, Nishikawa K, Shibouta Y.
    Kidney Int Suppl; 1997 Dec; 63():S136-9. PubMed ID: 9407442
    [Abstract] [Full Text] [Related]

  • 3. Effects of candesartan cilexetil on oxidative state and renal function in 5/6 nephrectomized rats.
    Sugimoto K, Tsuruoka S, Matsushita K, Fujimura A.
    J Hum Hypertens; 1999 Jan; 13 Suppl 1():S63-70; discussion S81. PubMed ID: 10076923
    [Abstract] [Full Text] [Related]

  • 4. Effect of candesartan cilexetil (TCV-116) in rats with chronic renal failure.
    Noda M, Matsuo T, Fukuda R, Ohta M, Nagano H, Shibouta Y, Naka T, Nishikawa K, Imura Y.
    Kidney Int; 1999 Sep; 56(3):898-909. PubMed ID: 10469358
    [Abstract] [Full Text] [Related]

  • 5. Acute effects of candesartan cilexetil (the new angiotensin II antagonist) on systemic and renal haemodynamics in hypertensive patients.
    Fridman K, Andersson OK, Wysocki M, Friberg P, Sunzel M.
    Eur J Clin Pharmacol; 1998 Sep; 54(7):497-501. PubMed ID: 9832289
    [Abstract] [Full Text] [Related]

  • 6. Use of candesartan cilexetil decreases proteinuria in renal transplant patients with chronic allograft dysfunction.
    Omoto K, Tanabe K, Tokumoto T, Shimmura H, Ishida H, Toma H.
    Transplantation; 2003 Oct 27; 76(8):1170-4. PubMed ID: 14578748
    [Abstract] [Full Text] [Related]

  • 7. Candesartan cilexetil protects against loss of autoregulatory efficiency in angiotensin II-infused rats.
    Inscho EW, Imig JD, Deichmann PC, Cook AK.
    J Am Soc Nephrol; 1999 Jan 27; 10 Suppl 11():S178-83. PubMed ID: 9892160
    [Abstract] [Full Text] [Related]

  • 8. Angiotensin type 1 and type 2 receptor blockade in chronic allograft nephropathy.
    Lutz J, Risch K, Liu S, Antus B, Schmaderer C, Roos M, Ouyang N, Lehmann M, Heemann U.
    Kidney Int; 2006 Sep 27; 70(6):1080-8. PubMed ID: 16850018
    [Abstract] [Full Text] [Related]

  • 9. [Candesartan cilexetil: pharmacological properties and protective effects against organ damage of a novel nonpeptide angiotensin II-receptor antagonist].
    Inada Y, Naka T.
    Nihon Yakurigaku Zasshi; 2000 Mar 27; 115(3):151-60. PubMed ID: 10876800
    [Abstract] [Full Text] [Related]

  • 10. Renal allograft protection with losartan in Fisher-->Lewis rats: hemodynamics, macrophages, and cytokines.
    Ziai F, Nagano H, Kusaka M, Coito AJ, Troy JL, Nadeau KC, Rennke HG, Tilney NL, Brenner BM, MacKenzie HS.
    Kidney Int; 2000 Jun 27; 57(6):2618-25. PubMed ID: 10844632
    [Abstract] [Full Text] [Related]

  • 11. Pharmacologic properties of candesartan cilexetil--possible mechanisms of long-acting antihypertensive action.
    Inada Y, Ojima M, Kanagawa R, Misumi Y, Nishikawa K, Naka T.
    J Hum Hypertens; 1999 Jan 27; 13 Suppl 1():S75-80. PubMed ID: 10076925
    [Abstract] [Full Text] [Related]

  • 12. Persistent cardiovascular effects of chronic renin-angiotensin system inhibition following withdrawal in adult spontaneously hypertensive rats.
    Paull JR, Widdop RE.
    J Hypertens; 2001 Aug 27; 19(8):1393-402. PubMed ID: 11518847
    [Abstract] [Full Text] [Related]

  • 13. Effects of acute AT1 receptor blockade by candesartan on arterial pressure and renal function in rats.
    Cervenka L, Wang CT, Navar LG.
    Am J Physiol; 1998 May 27; 274(5):F940-5. PubMed ID: 9612332
    [Abstract] [Full Text] [Related]

  • 14. In vivo inhibition of angiotensin receptors in the rat kidney by candesartan cilexetil: a comparison with losartan.
    Fabiani ME, Dinh DT, Nassis L, Casley DJ, Johnston CI.
    Am J Hypertens; 2000 Sep 27; 13(9):1005-13. PubMed ID: 10981551
    [Abstract] [Full Text] [Related]

  • 15. Candesartan cilexetil reduces graft arteriosclerosis in aortic transplantation model in rat.
    Zezina L, Larsson E, Fellström B.
    Transpl Immunol; 2001 Feb 27; 8(4):245-51. PubMed ID: 11316067
    [Abstract] [Full Text] [Related]

  • 16. Renal mass as a determinant of late allograft outcome: insights from experimental studies in rats.
    Mackenzie HS, Azuma H, Rennke HG, Tilney NL, Brenner BM.
    Kidney Int Suppl; 1995 Dec 27; 52():S38-42. PubMed ID: 8587281
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetic-pharmacodynamic interactions of candesartan cilexetil and losartan.
    Azizi M, Chatellier G, Guyene TT, Ménard J.
    J Hypertens; 1999 Apr 27; 17(4):561-8. PubMed ID: 10404959
    [Abstract] [Full Text] [Related]

  • 18. Comparison of the antihypertensive effects of the new angiotensin II (AT1) receptor antagonist candesartan cilexetil (TCV-116) and the angiotensin converting enzyme inhibitor enalapril in rats.
    Wada T, Inada Y, Ojima M, Sanada T, Shibouta Y, Nishikawa K.
    Hypertens Res; 1996 Jun 27; 19(2):75-81. PubMed ID: 10968199
    [Abstract] [Full Text] [Related]

  • 19. Candesartan improves blood pressure control and reduces proteinuria in renal transplant recipients: results from SECRET.
    Philipp T, Martinez F, Geiger H, Moulin B, Mourad G, Schmieder R, Lièvre M, Heemann U, Legendre C.
    Nephrol Dial Transplant; 2010 Mar 27; 25(3):967-76. PubMed ID: 19887503
    [Abstract] [Full Text] [Related]

  • 20. The angiotensin receptor antagonist, irbesartan, reduces renal injury in experimental chronic renal failure.
    Ziai F, Ots M, Provoost AP, Troy JL, Rennke HG, Brenner BM, Mackenzie HS.
    Kidney Int Suppl; 1996 Dec 27; 57():S132-6. PubMed ID: 8941934
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.